BioCentury
ARTICLE | Politics & Policy

Second Brady amendment removes potentially disruptive provision on non-qualified deferred compensation

November 10, 2017 12:30 AM UTC

A provision related to the tax treatment of non-qualified deferred compensation that could have caused a fundamental change in pay practices across the biotech industry was scrapped on Thursday.

House Ways and Means Committee Chairman Kevin Brady (R-Texas) unveiled a second wave of amendments to the Tax Cuts and Jobs Act (H.R. 1) bill, and among the modifications was the removal of Section 3801 pertaining to non-qualified deferred compensation...